Lena Land
About Lena Land
Lena Land is the Senior Manager Access & Value Strategy Hematology at Bristol Myers Squibb in Munich, Germany, with over a decade of experience in market access and value strategy, particularly in hematology and immuno-oncology.
Current Position
Lena Land currently serves as the Senior Manager Access & Value Strategy Hematology at Bristol Myers Squibb. She is based in Munich, Bavaria, Germany, and focuses on developing strategies to enhance market access and value within the hematology sector. Her role contributes to the strategic planning and execution necessary for product introduction and market success within this specialized field.
Previous Roles at AstraZeneca
Before joining Bristol Myers Squibb, Lena Land held several positions at AstraZeneca, accumulating extensive experience over several years. She began as an Intern in Market Access in 2013, advanced to the role of Junior Manager Market Access, and eventually became Market Access Manager. In 2017, she briefly served as EU Market Access Lead for Immuno-Oncology. Her tenure at AstraZeneca showcased her ability to handle increasingly complex responsibilities within market access and value strategy.
Educational Background
Lena Land holds a Master of Public Health (MPH) from Ludwig-Maximilians-Universität München, achieved between 2012 and 2014. Prior to this, she completed her Bachelor of Arts (BA) in Public Health from Uni Bremen, studying from 2009 to 2012. Her academic background in public health has provided her with a strong foundation for her career in market access and value strategy.
Early Career and Internships
Lena Land's early career is marked by a series of internships and roles that enriched her experience in epidemiology and public health. She interned at the Leibniz - Institut für Präventionsforschung und Epidemiologie B.I.P.S. GmbH in several capacities, including Clinical Epidemiology and as a Diplomandin. She also gained experience in the Epidemiology Group at the University of Aberdeen in Scotland. Additionally, she worked as a tutor in epidemiology at Uni Bremen, further solidifying her strong academic involvement.
Expertise in Market Access and Value Strategy
With over a decade of experience in market access and value strategy, Lena Land has developed a deep expertise in these areas, particularly in hematology. Her professional journey reflects a diverse range of roles that include developing market access strategies for immuno-oncology and various other therapeutic areas. Her international work experience spans Germany and the United Kingdom, demonstrating her capacity to adapt and thrive in different healthcare settings.